Bafna Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication for the Audited Financial Results of the Company for the Quarter & Year ended March 31, 2026 as published in "Financial Express" and "Makkal Kural" on May 31, 2026.
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bafna Pharmaceuticals has submitted to NSE a copy of the newspaper advertisement publishing its audited financial results for the fourth quarter and full financial year ended March 31, 2026. The results were published in 'Financial Express' (English) and 'Makkal Kural' (Tamil) on May 31, 2026. This is a standard regulatory compliance filing under SEBI listing requirements, which mandate listed companies to publish quarterly/annual results in at least one English and one regional language newspaper. The actual financial numbers are not disclosed in this announcement itself — investors would need to refer to the published results or the company's detailed financial filings for specific figures.
This is a routine compliance disclosure with no direct impact on share price or shareholder value. Investors seeking the actual financial performance details should review the published audited results or the company's standalone financial filings on the BSE/NSE portals.